SLC1A2 and schizophrenia: EAAT2 dysfunction, associated with higher ambient glutamate levels, has been observed in neurodegenerative and psychiatric diseases including Huntington's, Parkinson's, Alzheimer's and schizophrenia in which cognitive functions are impaired7, 10, 11.